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OBJECTIVE

RESULTS

RESULTS

• The objective of this study was to evaluate adherence to institutional
restriction criteria for intravenous acetaminophen use in the emergency
departments within a community hospital system.

BACKGROUND
• Intravenous (IV) acetaminophen is an analgesic frequently used instead of
opioids in the emergency departments (ED) across Parkview Health.
• Current literature demonstrates comparable efficacy for pain relief with IV
acetaminophen when compared to other intravenous pain medications, while
other data suggesting little additional benefit with IV acetaminophen.
• Casey et al. found that the use of oral acetaminophen in patients with geriatric
hip fractures was associated with better pain control and patients in the oral
acetaminophen group used less opioids.1
• Barnaby et al. compared 1 gram of IV acetaminophen with 1 mg of IV
hydromorphone in adults with acute pain in the ED. The hydromorphone
group had statistically greater analgesia effects.2
• Biok et al. evaluated the addition of IV acetaminophen did not decrease opioid
requirement in adult patients with acute pain during their ED stay.3
• IV acetaminophen is significantly more expensive than other oral, rectal, and
intravenous alternatives which leads to restricted use criteria at Parkview
Health.

METHODS
• Institutional Review Board (IRB) approved retrospective chart review of
patients treated in the Parkview Health ED between March 1, 2019 and
March 30, 2020.
• Inclusions: > 18 years old, in the ED, and received at least 1 dose of IV
acetaminophen.
• Exclusions: did not have at least one recorded pain score after IV
acetaminophen administration.
• Primary endpoint: number of inappropriate IV acetaminophen doses given in
the ED as defined by the current restriction criteria within the health system.
• ED restriction criteria: patients greater than 65 years of age with hip fracture
or for surgical patients in the peri-operative period.

RESULTS

DISCUSSION & CONCLUSIONS
• Data analysis from this retrospective medication use evaluation shows that
62.4% of IV acetaminophen doses are ordered for patients that do not
meet criteria for use.
• Auto-verification was used on 66.7% of all IV acetaminophen doses, with
39.6% of those orders being inappropriate based on restriction criteria.
Removing acetaminophen from the auto-varication list would allow more
pharmacist intervention.
• The total study population experienced a mean decrease in pain scores of
1.6 + 3.3 after the administration of intravenous acetaminophen. Since
61.7% of patients required additional analgesic medications, this may
indicate that IV acetaminophen may not be adequate alone for pain control.
• Future Directions
• Education for providers on non-oral analgesics, multi-modal pain control,
and review of restriction criteria is needed to limit inappropriate ordering
of intravenous acetaminophen for patients in the ED.
• Take off the auto verify list.
• Further limitations can be put on providers by not supplying IV
acetaminophen in the ED Pyxis. Having the medication come from main
pharmacy allows for pharmacy intervention in doses that do not meet
the institution’s restriction criteria.
• Increase awareness of the atraumatic headache pain panel and nonopioid pain panels to give providers other tools to help with pain control.

REFERENCES
1. Casey SD, Stevenson DE, Mumma BE, et al. Emergency Department Pain Management Following Implementation of a
Geriatric Hip Fracture Program. West J Emerg Med. 2017;18(4):585-591.
2. Barnaby DP, Chertoff AE, Restivo AJ, et al. Randomized Controlled Trial of Intravenous Acetaminophen Versus
Intravenous Hydromorphone for the Treatment of Acute Pain in the Emergency Department. Ann Emerg Med.
2019;73(2):133-140.
3. Blok Z, Ridderikhof ML, Goddijn H, et al. Intravenous acetaminophen does not have an opioid sparing effect in
Emergency Department patients with painful conditions. Emerg Med J. 2020;10.1016/j.ajem.2020.01.049
4. Bollinger AJ, Butler PD, Nies MS, at el. Is Scheduled Intravenous Acetaminophen Effective in the Pain Management
Protocol of Geriatric Hip Fractures?. Geriatr Orthop Surg Rehabil. 2015;6(3):202-208.
5. Bijur PE, Friedman BW, White D, et al. Randomized Clinical Trial of Intravenous (IV) Acetaminophen as an Adjunct to
IV Hydromorphone for Acute Severe Pain in Emergency Department Patients. Acad Emerg Med.
2020;10.1111/acem.13947.
6. Furyk J, Levas D, Close B, et al. Intravenous versus oral paracetamol for acute pain in adults in the emergency
department setting: a prospective, double-blind, double-dummy, randomized controlled trial. Emerg Med J.
2018;35(3):179-184.
Special thanks to Sarah Ferrell, PharmD for her contributions.
Disclosure
The authors of this presentation have the following to disclose concerning possible financial or personal relationships with commercial entities that
may have a direct or indirect interest in the subject matter of this presentation:
Allison Clemens: Nothing to disclose | Sarah Meeks: Nothing to disclose | Bryan Statz: Nothing to disclose
| | | 2020 ASHP Midyear Clinical Meeting / Virtual / Poster # ##-### | | |

